EDAP TMS S.A. - AMERICAN DEPOSITARY SHARES EACH R

EDAP Reports First Quarter 2021 Results and Provides Operational Update

11 May 2021 13:30:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021

04 May 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP Announces Pricing of Follow-On Offering

22 Apr 2021 23:30:00 By Nasdaq GlobeNewswire

EDAP Announces Launch of Follow-On Offering

22 Apr 2021 13:01:00 By Nasdaq GlobeNewswire

EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update

30 Mar 2021 13:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021

23 Mar 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US   

03 Mar 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year

20 Jan 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 Jan 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery

14 Jan 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP Issues Letter to Shareholders

06 Jan 2021 05:00:00 By Nasdaq GlobeNewswire

EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

05 Jan 2021 05:00:00 By Nasdaq GlobeNewswire